White House on board with FDA guidelines for vetting COVID-19 vaccines

• Despite earlier opposition to the FDA's approach to evaluating the safety of widespread deployment of COVID-19 vaccines, if approved, the Trump administration has how endorsed the agency's plans.
• Although remote beforehand, the White House's support of the guidelines practically eliminates the possibility of an FDA nod before election day since they include a two-month post-vaccination observation period to ascertain any negative side effects.
• https://seekingalpha.com/news/3620249-white-house-on-board-fda-guidelines-for-vetting-covidminus-19-vaccines